Susquehanna International Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Sell |
212,572
-14,900
| -7% | -$34.4K | ﹤0.01% | 4341 |
|
|
2025
Q1 | $316K | Buy |
227,472
+85,009
| +60% | +$118K | ﹤0.01% | 4963 |
|
|
2024
Q4 | $246K | Sell |
142,463
-34,029
| -19% | -$58.9K | ﹤0.01% | 5003 |
|
|
2024
Q3 | $355K | Buy |
176,492
+47,292
| +37% | +$95.1K | ﹤0.01% | 4089 |
|
|
2024
Q2 | $289K | Sell |
129,200
-1,180,427
| -90% | -$2.64M | ﹤0.01% | 4252 |
|
|
2024
Q1 | $3.76M | Sell |
1,309,627
-118,519
| -8% | -$340K | ﹤0.01% | 1233 |
|
|
2023
Q4 | $2.53M | Buy |
1,428,146
+1,225,529
| +605% | +$2.17M | ﹤0.01% | 1699 |
|
|
2023
Q3 | $640K | Buy |
+202,617
| New | +$640K | ﹤0.01% | 3091 |
|
|
2023
Q2 | – | Sell |
-100,044
| Closed | -$79.8K | – | 6468 |
|
|
2023
Q1 | $79.8K | Sell |
100,044
-60,680
| -38% | -$48.4K | ﹤0.01% | 5319 |
|
|
2022
Q4 | $363K | Buy |
+160,724
| New | +$363K | ﹤0.01% | 3642 |
|
|
2022
Q3 | – | Sell |
-21,163
| Closed | -$79K | – | 6902 |
|
|
2022
Q2 | $79K | Buy |
+21,163
| New | +$79K | ﹤0.01% | 5100 |
|